MEDL Retained to Mobilize Health Initiative From UCLA and University of Michigan

FOUNTAIN VALLEY, Calif., April 1, 2014 (GLOBE NEWSWIRE) -- MEDL Mobile, Inc. (OTCBB:MEDL) – a pioneer in the creation, development, marketing and monetization of mobile apps – today announced that the company has been retained to create a native mobile experience for the My GI Health Patient-Provider Portal. My GI Health is a collaboration between the academic research institutions UCLA and the University of Michigan, researchers, educators, physicians, pharmaceutical companies and food and beverage companies.

My GI Health is a Patient-Provider Portal (P3) that provides clinicians with a comprehensive assessment and history of a patient's Gastro Intestinal (GI) symptoms, detailed data on patients' symptoms over time, and an educational prescription for each patient tailored to their specific needs, all accessible from the electronic health record (EHR) console. My GI Health condenses the patient's responses into reports for both the patient and provider.

Additionally, My GI Health provides the clinician with a clinical history that is translated into "doctor speak" and can be incorporated directly into the patient's electronic medical record. A provider is able to review both the patient's GI symptom scores and history to understand the patient's complaints before they enter the exam room, leaving more time for interaction and conversation with the patient.

The team from MEDL will work alongside the team from My GI Health to create an iOS7 optimized experience that enhances the existing platform with native iPhone and iPad functionality.

"The future of healthcare is clearly mobile," said Dave Swartz, MEDL Mobile Co-Founder. "We are thrilled that such prestigious organizations as UCLA and University of Michigan have chosen MEDL to extend their vision for a patient-physician relationship to the mobile device."

For more information about My GI Health, refer to this video:

About MEDL Mobile

MEDL has led mobile strategy, ideation, development, marketing and monetization for many of the biggest names on the planet - in areas diverse as entertainment, telecom, medicine, education and retail - for such prestigious clients as Hyundai, Taco Bell,, The New York Times Company, and Telefonica. The Company enters into partnerships to mobilize and monetize IP with such notable names as Encyclopedia Britannica, Real Madrid, Cheech & Chong and Marlee Matlin.

MEDL has developed several mobile applications for clients in healthcare and related markets such as Kaiser Permanente, Medtronic, and the global clinical trials recruitment agency, BBK Worldwide.

MEDL is the largest shareholder of Hang With, Inc.

For more information about MEDL Mobile, please visit

Forward-Looking Statements

Certain statements contained herein constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations, estimates and projections about MEDL Mobile's industry, management's beliefs and certain assumptions made by management. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Because such statements involve risks and uncertainties, the actual results and performance of the Company may differ materially from the results expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Potential risks and uncertainties include but are not limited to the ability to integrate Inedible Software apps and platform into MEDL's product offering, the ability to procure, properly price, retain and successfully complete projects, and changes in products and competition. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made here. Readers should review carefully reports or documents the Company files periodically with the Securities and Exchange Commission.

For more information about MEDL Mobile, please visit

CONTACT: Media Contact: DJ Swanepoel MEDL Mobile 714-617-1991 ex. 4211Source:MEDL Mobile Holdings, Inc.